Table 3.
Logistic regression analysis of the association between mental disorders and risk of death due to COVID-19.
| Variables | Death risk due to COVID-19 | |||||||
|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | |||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95%CI) | p-value | OR (95% CI) | p-value | |
| Psychotic disorders | 2.87 (1.22–6.75) | 0.016 | 2.77 (1.10–7.01) | 0.031 | 2.29 (0.82–6.37) | 0.11 | 1.88 (0.68–5.23) | 0.23 |
| Substance use disorder | 1.84 (1.40–2.41) | <0.001 | 1.60 (1.20–2.14) | 0.001 | 1.59 (1.18–2.16) | 0.003 | 1.23 (0.90–1.69) | 0.20 |
| Bipolar affective disorder | 4.50 (2.34–8.66) | <0.001 | 4.50 (2.18–9.27) | <0.001 | 4.77 (2.31–9.87) | <0.001 | 3.69 (1.78–7.67) | <0.001 |
| Dementia | 6.29 (4.70–8.42) | <0.001 | 2.03 (1.49–2.76) | <0.001 | 2.25 (1.63–3.10) | <0.001 | 2.06 (1.49–2.85) | <0.001 |
| Alzheimer disease | 5.97 (4.29–8.32) | <0.001 | 1.85 (1.31–2.63) | 0.001 | 2.18 (1.52–3.11) | <0.001 | 2.13 (1.48–3.06) | <0.001 |
| Vascular dementia | 3.71 (1.43–9.62) | 0.007 | 1.20 (0.45–3.18) | 0.71 | 1.33 (0.50–3.52) | 0.57 | 0.91 (0.33–2.45) | 0.84 |
| Secondary dementia | 7.30 (4.26–12.53) | <0.001 | 2.69 (1.53–4.75) | 0.001 | 2.68 (1.47–4.88) | 0.001 | 2.09 (1.13–3.85) | 0.019 |
| Anxiety | 1.71 (1.19–2.44) | 0.003 | 1.57 (1.07–2.29) | 0.02 | 1.56 (1.06–2.31) | 0.024 | 1.27 (0.85–1.89) | 0.24 |
| Late-life anxiety | 2.36 (1.64–3.39) | <0.001 | 1.61 (1.10–2.35) | 0.014 | 1.60 (1.09–2.37) | 0.018 | 1.30 (0.87–1.94) | 0.20 |
| Depression | 2.04 (1.56–2.67) | <0.001 | 2.08 (1.57–2.77) | <0.001 | 2.03 (1.51–2.72) | <0.001 | 1.57 (1.16–2.13) | 0.004 |
| Late-life | 2.59 (1.96–3.41) | <0.001 | 1.97 (1.47–2.63) | <0.001 | 1.90 (1.40–2.57) | <0.001 | 1.46 (1.07–2.00) | 0.017 |
| Depression comorbid with anxiety | 1.84 (1.10–3.09) | 0.02 | 1.87 (1.09–3.24) | 0.024 | 1.67 (0.93–2.97) | 0.08 | 1.31 (0.73–2.36) | 0.36 |
| Late-life | 2.43 (1.44–4.10) | 0.001 | 1.92 (1.11–3.32) | 0.02 | 1.71 (0.95–3.05) | 0.07 | 1.35 (0.75–2.42) | 0.32 |
Model 1 unadjusted.
Model 2 analyses were adjusted for age and sex.
Model 3 analyses were further adjusted for education, ethnicity, and BMI.
Model 4 Analyses were further adjusted for cerebrovascular disease, diabetes, hypertension, coronary artery disease, cancer, and respiratory disease.